Editas Medicine, Inc.

Symbol: EDIT

NASDAQ

6.58

USD

Market price today

  • -3.5903

    P/E Ratio

  • 0.0278

    PEG Ratio

  • 538.33M

    MRK Cap

  • 0.00%

    DIV Yield

Editas Medicine, Inc. (EDIT) Financial Statements

On the chart you can see the default numbers in dynamics for Editas Medicine, Inc. (EDIT). Companys revenue shows the average of 28.799 M which is 0.944 % gowth. The average gross profit for the whole period is 1.564 M which is 0.671 %. The average gross profit ratio is 0.194 %. The net income growth for the company last year performance is -0.250 % which equals -0.488 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Editas Medicine, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.029. In the realm of current assets, EDIT clocks in at 340.829 in the reporting currency. A significant portion of these assets, precisely 323.111, is held in cash and short-term investments. This segment shows a change of -0.261% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 107.901, if any, in the reporting currency. This indicates a difference of 15.902% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 24.372 in the reporting currency. This figure signifies a year_over_year change of -0.169%. Shareholder value, as depicted by the total shareholder equity, is valued at 349.097 in the reporting currency. The year over year change in this aspect is -0.032%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 10.187, with an inventory valuation of 0, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 0.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013

balance-sheet.row.cash-and-short-term-investments

1651.34323.1437.4619.9
511.8
457.1
369
329.1
185.3
143.2
10.6
2

balance-sheet.row.short-term-investments

867.11199.5202.8296.3
262.4
219
234.2
182.5
0
0
0
0

balance-sheet.row.net-receivables

15.1410.25.10.3
6
0.4
0
0.7
0.1
1
0
0

balance-sheet.row.inventory

-140.390-93.1-120.1
-109.7
0
2.9
1.9
1.7
0.8
0
0

balance-sheet.row.other-current-assets

26.67.57.37.2
10.9
6.3
2.9
0.5
0.1
0
0.1
0.1

balance-sheet.row.total-current-assets

1552.68340.8356.8507.3
419.1
463.8
374.8
332.2
187.2
145
10.7
2.1

balance-sheet.row.property-plant-equipment-net

186.4245.759.243.3
39.1
39.6
40.2
39.4
40.4
2.1
1.1
0.1

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

336.1107.993.1120.1
109.7
5.3
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

-65.344.75.36.8
4.7
0.1
5.4
1.6
1.6
2.2
0.4
0.3

balance-sheet.row.total-non-current-assets

457.18158.3157.6170.2
153.5
45
45.6
41.1
42
4.4
1.5
0.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

2009.86499.2514.3677.5
572.6
508.9
420.4
373.3
229.2
149.4
12.2
2.5

balance-sheet.row.account-payables

35.798.39.55
6.4
5.8
5.3
4
4.6
1.4
2.6
0.4

balance-sheet.row.short-term-debt

40.5112.211.110.3
6.8
5.8
12.8
7.5
10
0
0.1
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

104.9624.432.916.1
19.3
23.3
32.4
33.4
35.1
199.9
0.3
2.1

Deferred Revenue Non Current

242.6760.760.760.9
74
163.2
115.6
94.7
26
25.3
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

124.334.631.320.2
24
24.8
2
11.9
-7.6
5.5
1.8
1.7

balance-sheet.row.total-non-current-liabilities

324.5186.893.577
120.8
186.5
148.3
128.5
61.5
225.6
21.3
2.1

balance-sheet.row.other-liabilities

24.92000
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

133.3124.443.926.4
26.1
29.1
32.4
33.4
35.1
0
0
0

balance-sheet.row.total-liab

582.91150.1153.6123.8
179
246.4
184.2
165.2
94.6
232.5
27.5
4.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
229.2
21.1
0
0

balance-sheet.row.common-stock

0.03000
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

-4738.45-1231.3-1078.1-857.7
-665.2
-549.2
-416.3
-305.9
-185.5
-88.3
-15.4
-1.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

-5.820.2-3.6-0.5
0
0.1
0
-0.1
-229.2
0
0
0

balance-sheet.row.other-total-stockholders-equity

6171.191580.21442.41411.8
1058.8
811.5
652.5
514
320.1
-15.9
0.2
0

balance-sheet.row.total-stockholders-equity

1426.95349.1360.7553.6
393.6
262.4
236.2
208.1
134.6
-83.1
-15.3
-1.8

balance-sheet.row.total-liabilities-and-stockholders-equity

2009.86499.2514.3677.5
572.6
508.9
420.4
373.3
229.2
149.4
12.2
2.5

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

1426.95349.1360.7553.6
393.6
262.4
236.2
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

2009.86---
-
-
-
-
-
-
-
-

Total Investments

1058.35307.4295.8416.4
372.1
219
234.2
182.5
0
0
0
0

balance-sheet.row.total-debt

145.4736.543.926.4
26.1
29.1
32.4
33.4
35.1
199.9
0.4
2.1

balance-sheet.row.net-debt

-410.56-87.1-97.6-177.1
-113.5
-209.1
-102.4
-113.2
-150.2
56.7
-10.2
0.1

Cash Flow Statement

The financial landscape of Editas Medicine, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 0.246. The company recently extended its share capital by issuing 118.04, marking a difference of 14.286 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to -3731000.000 in the reporting currency. This is a shift of -1.033 from the previous year. In the same period, the company recorded 6.06, 0, and 0, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 0.96, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

cash-flows.row.net-income

-153.22-153.2-220.4-192.5
-116
-133.7
-110
-120.3
-97.2
-72.9
-13.7

cash-flows.row.depreciation-and-amortization

6.066.16.35.1
4
2.8
3.3
2.7
1.2
0.5
0.2

cash-flows.row.deferred-income-tax

-16.846.500
-16.4
0
-3.7
0
0.1
0.1
0

cash-flows.row.stock-based-compensation

19.819.829.343.4
23.2
27.2
26.6
23.4
16.9
3.5
0.1

cash-flows.row.change-in-working-capital

-1.59-1.68.2-21.4
-102.2
65.9
26.9
70.7
18.5
63.1
4.1

cash-flows.row.account-receivables

-5.04-5-4.95.8
-5.6
-0.4
0.6
-0.6
0.9
-1
0

cash-flows.row.inventory

000-3.3
-5.7
10.7
1.6
-8.9
13.1
4.8
0

cash-flows.row.account-payables

-1.49-1.54.4-1.1
0.9
0.3
1.8
-1.5
3.3
-1.4
2.2

cash-flows.row.other-working-capital

4.944.98.7-22.7
-91.8
55.4
22.9
81.7
1.2
60.8
1.9

cash-flows.row.other-non-cash-items

13.61-9.8-0.71.7
27.6
-2.9
11.2
14.2
10.6
0.3
0.7

cash-flows.row.net-cash-provided-by-operating-activities

-132.18000
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-4.72-4.7-4.1-8
-7.2
-6.2
-4.8
-2.1
-3.5
-1.4
-1.2

cash-flows.row.acquisitions-net

63.160046.5
0
0.1
0
0
0
0
0

cash-flows.row.purchases-of-investments

-258.52-258.5-315.2-408.9
-458.4
-342.2
-459.4
-375.3
0
0.2
0

cash-flows.row.sales-maturities-of-investments

259.5259.5433.4362.4
325
360.5
411
193.5
0
0
0

cash-flows.row.other-investing-activites

-63.1600-46.5
0
0
0
0
-1.6
-0.2
0

cash-flows.row.net-cash-used-for-investing-activites

-3.73-3.7114.1-54.5
-140.5
12.3
-53.1
-183.8
-5.1
-1.4
-1.2

cash-flows.row.debt-repayment

0000
0
0
-0.9
-1.4
-0.6
-2.1
0

cash-flows.row.common-stock-issued

118.041181249.5
203.7
116.3
76.8
154.1
97.5
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
-0.8
-143.2
0

cash-flows.row.other-financing-activites

117.5310.332.6
20.4
15.5
11
1.8
1
284.6
18.4

cash-flows.row.net-cash-used-provided-by-financing-activities

118.041181.3282.1
224.1
131.8
86.9
154.5
97.2
139.4
18.5

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-17.87-17.9-6263.8
-96.2
103.4
-11.9
-38.7
42.1
132.6
8.6

cash-flows.row.cash-at-end-of-period

567.66123.7145.4207.4
143.6
239.8
136.4
148.2
185.3
143.2
10.6

cash-flows.row.cash-at-beginning-of-period

585.53141.5207.4143.6
239.8
136.4
148.2
186.9
143.2
10.6
2

cash-flows.row.operating-cash-flow

-132.18-132.2-177.3-163.8
-179.8
-40.7
-45.7
-9.4
-49.9
-5.4
-8.7

cash-flows.row.capital-expenditure

-4.72-4.7-4.1-8
-7.2
-6.2
-4.8
-2.1
-3.5
-1.4
-1.2

cash-flows.row.free-cash-flow

-136.9-136.9-181.5-171.8
-187
-46.8
-50.5
-11.5
-53.4
-6.8
-9.9

Income Statement Row

Editas Medicine, Inc.'s revenue saw a change of 2.963% compared with the previous period. The gross profit of EDIT is reported to be 72.06. The company's operating expenses are 241.24, showing a change of -1.800% from the last year. The expenses for depreciation and amortization are 6.06, which is a -0.043% change from the last accounting period. Operating expenses are reported to be 241.24, which shows a -1.800% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.251% year-over-year growth. The operating income is -169.18, which shows a -0.251% change when compared to the previous year. The change in the net income is -0.250%. The net income for the last year was -153.22.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

income-statement-row.row.total-revenue

78.1278.119.725.5
90.7
20.5
31.9
13.7
6.1
1.6
0

income-statement-row.row.cost-of-revenue

6.066.16.35.1
158
96.9
0
0
0
0
0

income-statement-row.row.gross-profit

72.0672.113.420.5
-67.3
-76.4
31.9
13.7
6.1
1.6
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0

income-statement-row.row.research-development

141.01---
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

69.65---
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

33.57-1.61.3-1.7
16.3
-0.1
0.3
0.6
-0.1
-37.4
-0.9

income-statement-row.row.operating-expenses

245.84241.2245.7218.7
225.6
161.5
145.7
133.7
103.2
36.9
12.7

income-statement-row.row.cost-and-expenses

247.3247.3245.7218.7
225.6
161.5
145.7
133.7
103.2
36.9
12.7

income-statement-row.row.interest-income

17.5717.64.22.3
2.6
7.3
0
0
0
0
0

income-statement-row.row.interest-expense

-3.4704.20
0
-7.3
-3.4
1
-0.1
0.1
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

12.15165.50.6
18.9
7.2
0.3
0.6
-0.1
-37.4
-0.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

33.57-1.61.3-1.7
16.3
-0.1
0.3
0.6
-0.1
-37.4
-0.9

income-statement-row.row.total-operating-expenses

12.15165.50.6
18.9
7.2
0.3
0.6
-0.1
-37.4
-0.9

income-statement-row.row.interest-expense

-3.4704.20
0
-7.3
-3.4
1
-0.1
0.1
0

income-statement-row.row.depreciation-and-amortization

6.066.16.35.1
4
-0.1
3.3
2.7
1.2
0.5
0.2

income-statement-row.row.ebitda-caps

-162.57---
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-164.04-169.2-225.9-193.1
-134.8
-140.9
-113.7
-119.9
-97.2
-35.3
-12.7

income-statement-row.row.income-before-tax

-153.22-153.2-220.4-192.5
-116
-133.7
-110
-120.3
-97.2
-72.9
-13.7

income-statement-row.row.income-tax-expense

-10.330-16.1-7.4
-6.6
-10.3
-3.1
-1.1
-1.3
-37.8
-0.9

income-statement-row.row.net-income

-149.75-153.2-204.4-185.1
-109.4
-123.5
-110
-120.3
-97.2
-72.9
-13.7

Frequently Asked Question

What is Editas Medicine, Inc. (EDIT) total assets?

Editas Medicine, Inc. (EDIT) total assets is 499153000.000.

What is enterprise annual revenue?

The annual revenue is 65385000.000.

What is firm profit margin?

Firm profit margin is 0.922.

What is company free cash flow?

The free cash flow is -1.675.

What is enterprise net profit margin?

The net profit margin is -1.917.

What is firm total revenue?

The total revenue is -2.100.

What is Editas Medicine, Inc. (EDIT) net profit (net income)?

The net profit (net income) is -153219000.000.

What is firm total debt?

The total debt is 36536000.000.

What is operating expences number?

The operating expences are 241240000.000.

What is company cash figure?

Enretprise cash is 123652000.000.